Thymosins in health & disease, the sixth international symposium
- PMID: 37012883
- DOI: 10.1016/j.intimp.2023.109889
Thymosins in health & disease, the sixth international symposium
Keywords: COVID; Cancer; Imnmunotherapy; Symposium; Thymosin.
Conflict of interest statement
Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: One of the authors (ALG) is Chairman of the Board of Directors & Chairman & Chief Scientific Advisor & a holder of stock in RegeneRX Biopharmaceuticals ,Inc. ,a company deeloping Thymosin B4 for the clinic.He is also a consultant for SciClone Phamaceuticals Inc a company producing Thymosin A1 for the clinic. The co-author (E.G.) is a holder of patents for Thymosin A1.